McKesson Corporation
Preço: 784.05Empresa e modelo de negócios
McKesson Corporation is a leading healthcare services and information technology company. It primarily operates in the distribution of pharmaceuticals and provides healthcare management solutions. Major business segments include pharmaceutical distribution, medical-surgical distribution, and healthcare technology. The company's main revenue sources are from the sale of prescription drugs, medical supplies, and related services to healthcare providers, pharmacies, and hospitals.
Perfil de investimento
The investment profile of McKesson Corporation is more aligned with value investors, given its stable revenue growth and modest dividend yield. The stock may appeal to those seeking a balanced approach, as it offers potential for capital appreciation alongside income generation. However, the higher risk factors suggest caution for investors.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 38.64 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- -9.3% ↓
- Surpresa de EPS
- 1.9% em linha
- Volatilidade 20d
- 1.4% estável
- Dividend yield
- 0.4% baixo última data ex-dividendo: 2026-06-01
Acompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-09 02:45 | Comprar | Vender | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-05 02:42 | Manter | Comprar | Mixed performance; cautious outlook amid market pressures. |
| 2026-06-01 02:44 | Vender | Manter | Weak momentum and high risk overshadow potential upside. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-05-08 14:52 | UBS | Preço-alvo elevado | 1000 → 1050 | 744.46 |
| 2026-05-08 12:53 | Deutsche Bank | Preço-alvo reduzido | 973 → 875 | 763.9 |
| 2026-03-05 15:28 | Raymond James | Atualizar | — → 970 | 930.31 |
Nada ainda